Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.2900
+0.0100 (3.57%)
Oct 16, 2026, 4:10 PM AEST
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 88.67 million as of October 16, 2026. It is the 28,479th most valuable company in the world and the 633rd biggest in Australia. Its market cap has decreased by 27.85% in one year.
Market Cap
88.67M
Enterprise Value
96.18M
Revenue
9.47M
Global Rank
Country Rank
#633 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 88.67M, an increase of 331.55%. That is a compound annual growth rate of 14.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 88.67M | -52.83% |
| Dec 31, 2025 | 187.97M | 67.15% |
| Dec 31, 2024 | 112.46M | 3.19% |
| Dec 29, 2023 | 108.98M | -7.28% |
| Dec 30, 2022 | 117.53M | -34.34% |
| Dec 31, 2021 | 179.00M | -2.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 132.09M |
| Nyrada | 116.37M |
| Island Pharmaceuticals | 102.15M |
| LTR Pharma | 85.67M |
| Alterity Therapeutics | 71.02M |
| Prescient Therapeutics | 66.34M |
| Neurizon Therapeutics | 63.17M |